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Prospects for research and clinical medicine in sleep bruxismIt is well-known that nonfunctional masticatory muscle
activities during sleep (sleep bruxism [SB]) are associated with a
wide range of symptoms in the orofacial region. For example, SB
is often associated with other temporomandibular joint and
masticatory muscle disorders, which in most cases can cause a
marked limitation in the daily activities of patients. Furthermore,
SB has also been associated with higher risks of mechanical and/
or technical complications not only in prosthodontic rehabilita-
tions, but also in natural teeth [1,2]. Thus appropriate diagnosis
and management of these muscle activities have been recognized
as one of the most important issues in prosthodontic medicine
over recent decades. However, methods to assess muscle
activities have failed to accurately and precisely detect and
measure the current ongoing conditions. Assessment based on a
patient’s awareness of SB has not been recognized as presenting
enough validity. The existence of teeth wear can probably
demonstrate the occurrence of a teeth-grinding habit, but it does
not clarify whether the habit is currently active, or whether it had
been only momentarily active in the past. An existence of other
intraoral findings, such as buccal mucosa ridging and torus
mandibularis, has also been considered as a possible marker;
however, a causal relationship with SB still remains unclear.
Over the years, numerous devices have been developed to enable
confirmation of clinical diagnosis of SB by electrophysiological
recordings (e.g., electromyography [EMG]), mainly at a sleep
laboratory. More recently, to decrease the burden to patients and
to avoid bias from a new sleep environment induced by sleep
laboratories, researchers and clinicians have applied portable
recording systems. Although a need remains for detailed
analyses of the validity and reliability of such portable recording
systems, accurate and convenient measurement of the SB level in
each individual in his home environment is progressing.
Hereafter, on the basis of an accurate and multiperspective
diagnosis, the next stage will be the time to provide
individualized medical care related to the specific needs of
each patient. Current management approaches are basically
mechanistic; i.e., they focus on preventing SB consequences.
The approach that is mostly recommended is the occlusal
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to prevent SB based, for example, on vibratory feedback
stimulation. Some case report series have demonstrated a
reduction in nocturnal muscle hyperactivity and symptoms in
the orofacial region [3,4]. Future innovative investigations are
required to promote advancement in splint-based therapies for
SB.
Alternative approaches focus on the complex molecular
mechanism involved in SB activity, which is still far from being
elucidated. Some attempts started with the consideration that
SB is a motor disorder. Based on the presumed metabolic
changes in the central nervous system of patients with SB,
several medications that control the release and receptor
binding of neurotransmitters, such as dopamine and serotonin,
have been used, but with insufficient efficacy. Recently, other
types of medications have also been tried, such as clonazepam
[5], and local injection of botulinum toxin has been shown to
reduce the frequency of SB events and SB-induced pain levels,
with effectiveness similar to oral splint therapy [6]. A
development of more-effective medication with lower side
effects is desirable to obtain a more specific drug-based
management of SB.
In conclusion, a new era of easy measurement of the SB
level in the individual’s home environment is on the way.
Concomitantly, novel insights into the molecular mechan-
isms of SB are also anticipated. Based on these advance-
ments, the development and implementation of novel and
individualized medical care for SB management are expected
to reduce the consequences and burden to patients.
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